Complementary effects of pine bark extract supplementation on inattention, impulsivity, and antioxidative status in children with attention-deficit hyperactivity disorder: A double-blinded randomized placebo-controlled cross-over study

被引:5
|
作者
Hsu, Cheng-Dien [1 ]
Hsieh, Li-Hsuan [2 ]
Chen, Ya-Ling [2 ]
Lin, I-Cheng [3 ]
Chen, Ying-Ru [3 ]
Chen, Chih-Chi [3 ]
Shirakawa, Hitoshi [4 ]
Yang, Suh-Ching [2 ,5 ,6 ]
机构
[1] Taiwan Adventist Hosp, Dept Psychiat, Taipei, Taiwan
[2] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei 11031, Taiwan
[3] Shuang Ho Hosp, Dept Psychiat, New Taipei, Taiwan
[4] Tohoku Univ, Grad Sch Agr Sci, Lab Nutr, Sendai, Miyagi, Japan
[5] Taipei Med Univ, Coll Nutr, Res Ctr Geriatr Nutr, Taipei, Taiwan
[6] Taipei Med Univ Hosp, Nutr Res Ctr, Taipei, Taiwan
关键词
attention‐ deficit hyperactivity disorder; oxidative stress; pine bark extract;
D O I
10.1002/ptr.7036
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to investigate the complementary effects of polyphenolic compounds from pine bark extract (PE) as a strong antioxidative substrate on the symptoms of inattention and impulsivity in children with attention-deficit hyperactivity disorder (ADHD). This was a randomized, double-blind, crossover, placebo-controlled study that included two experimental units (4 weeks with PE supplementation and 4 weeks with placebo supplementation) separated by a 2-week washout period. ADHD participants were supplemented with 25 mg or 50 mg PE. We recruited 20 participants (17 boys and 3 girls) with a mean age of 10.0 +/- 2.1 years. PE supplementation caused a significant reduction in the inattention and hyperactivity-impulsivity items of SNAP-IV. During the period of PE supplementation, the item of commissions in the Continuous Performance Test III (CPT III) significantly decreased, which was used to evaluate the symptoms of inattention and impulsivity. In addition, the erythrocytic reduced glutathione/oxidized glutathione ratio significantly increased, and the plasma TBARs level significantly decreased after 4 weeks of PE supplementation. However, there was no significant correlation between CPT III (commission) and antioxidative status indictors. PE supplementation may have potential effects of ameliorating inattention and impulsivity, and elevating the antioxidative status in children with ADHD.
引用
收藏
页码:3226 / 3235
页数:10
相关论文
共 50 条
  • [1] Effect of Neurofeedback Training on Aggression and Impulsivity in Children With Attention-Deficit/Hyperactivity Disorder: A Double-Blinded Randomized Controlled Trial
    Dashbozorgi, Zahra
    Ghaffari, Amin
    Esmaili, Samaneh Karamali
    Ashoori, Jamal
    Moradi, Ali
    Sarvghadi, Pooria
    BASIC AND CLINICAL NEUROSCIENCE, 2021, 12 (05) : 693 - 701
  • [2] Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial
    Maryam Rafeiy-Torghabeh
    Amir Ashraf-Ganjouei
    Kamyar Moradi
    Sayna Bagheri
    Mohammad-Reza Mohammadi
    Shahin Akhondzadeh
    European Child & Adolescent Psychiatry, 2021, 30 : 799 - 807
  • [3] Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial
    Rafeiy-Torghabeh, Maryam
    Ashraf-Ganjouei, Amir
    Moradi, Kamyar
    Bagheri, Sayna
    Mohammadi, Mohammad-Reza
    Akhondzadeh, Shahin
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2021, 30 (05) : 799 - 807
  • [4] Adjuvant effects of vitamin A and vitamin D supplementation on treatment of children with attention-deficit/hyperactivity disorder: a study protocol for a randomised, double-blinded, placebo-controlled, multicentric trial in China
    Zhou, Ping
    Wolraich, Mark Lee
    Cao, Ai-hua
    Jia, Fei-Yong
    Liu, Bin
    Zhu, Lin
    Liu, Yongfang
    Li, Xiaoli
    Li, Chao
    Peng, Bin
    Yang, Ting
    Chen, Jie
    Cheng, Qian
    Li, Tingyu
    Chen, Li
    BMJ OPEN, 2021, 11 (06):
  • [5] A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder
    Voigt, RG
    Llorente, AM
    Jensen, CL
    Fraley, JK
    Berretta, MC
    Heird, WC
    JOURNAL OF PEDIATRICS, 2001, 139 (02): : 189 - 196
  • [6] The Effects Of Nsaids On Performance And Muscle Soreness: A Placebo-controlled, Randomized, Double-blinded, Cross-over Study
    Sczuroski, Cara Elizabeth
    Staab, Jeffery S.
    Hughes, Julie M.
    Roberts, Brandon M.
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 829 - 829
  • [7] A DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER STUDY OF DEPRENYL IN CHILDREN WITH TOURETTES-SYNDROME (TS) AND ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)
    FEIGIN, A
    KURLAN, R
    MCDERMOTT, M
    DIMITSOPULOS, T
    TRINIDAD, K
    COMO, P
    BEACH, J
    CHAPIESKI, L
    JANKOVIC, J
    NEUROLOGY, 1995, 45 (04) : A254 - A255
  • [8] Placebo-controlled study examining effects of selegiline in children with attention-deficit/hyperactivity disorder
    Rubinstein, Suzanne
    Malone, Molly A.
    Roberts, Wendy
    Logan, William J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (04) : 404 - 415
  • [9] Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial
    Kooij, JJS
    Burger, H
    Boonstra, AM
    Van der Linden, PD
    Kalma, LE
    Buitelaar, JK
    PSYCHOLOGICAL MEDICINE, 2004, 34 (06) : 973 - 982
  • [10] A Randomized, Double-Blind, Placebo-Controlled Study of Atomoxetine in Japanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Takahashi, Michihiro
    Takita, Yasushi
    Yamazaki, Kosuke
    Hayashi, Takashi
    Ichikawa, Hironobu
    Kambayashi, Yasuko
    Koeda, Tatsuya
    Oki, Junichi
    Saito, Kazuhiko
    Takeshita, Kenzo
    Allen, Albert J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (04) : 341 - 350